Chiropractors in Lineville, AL Accepting Medicare
1 Chiropractors found. Showing 1 - 1
 Dr. Robert E Steele, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 89485 Hwy #9, Lineville, AL 36266 Phone: 256-396-2058 Fax: 256-396-2058 |
News Archive
New AGS position statement for ending gender discrimination: 'When women rise, we all rise'
Putting power and potential behind gender equity in health care isn't just common sense. It's critical to the future of health, safety, and independence for us all as we age, so says the American Geriatrics Society in a new position statement released today, International Day of Older Persons.
NYU researchers develop mobile self-care tools to mitigate onset of lymphedema
Each year, about 1.38 million women worldwide are diagnosed with breast cancer. Advances in diagnosis and treatment have facilitated a 90 percent, five-year survival rate, among those treated.
Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy
Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy, according to new information released today from a large scale controlled clinical study that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.
Automated navigation support reduces effort and injuries for surgeons
The Human Factors and Ergonomics Society congratulates Dietrich Manzey, Maria Luz, Stefan Mueller, Andreas Dietz, Juergen Meixensberger, and Gero Strauss on receiving the 2011 Human Factors Prize for their article, "Automation in Surgery: The Impact of Navigated-Control Assistance on Performance, Waorkload, Situation Awareness, and Acquisition of Surgical Skills."
Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.
› Verified 8 days ago